FDA to review benefits of LASIK surgery

SILVER SPRING -- The U.S. Food and Drug Administration plans to review whether LASIK, a popular type of laser eye surgery, is improving patients' lives.

The FDA says the move is in response to a number of concerns raised about patient satisfaction with the procedure.

Complications that patients can experience from LASIK include include dry eyes, glare, double vision, an increased risk of inflammation or infection in the cornea, and blindness.

An FDA advisory panel will hold a public meeting that will focus on patients' quality of life after surgery. The meeting could happen as soon as April.